Table 2. Risk for infection with avian influenza A (H7N7) with different levels of oseltamivir use, on the basis of combined conjunctivitis and serology-based case definition, the Netherlands, 2003*.
Oseltamivir use | Risk† (95% CI) |
---|---|
Not used | 0.145 (0.078–0.233) |
Not prescribed | 0.161 (0.052–0.336) |
Prescribed but not used during visit |
0.138 (0.061–0.246) |
Used | 0.031 (0.008–0.073) |
Prescribed and used consistently | 0.015 (0.0008–0.0630) |
Prescribed and used inconsistently | 0.049 (0.004–0.157) |
Prescribed and consistency of use unknown |
0.068 (0.004–0.258) |
Unknown | 0.019 (0.001–0.080) |
Prescribed but period of use unknown | 0.020 (0.001–0.080) |
*CI, confidence interval. †Probability of infection per visit.